DC isoketal-modified proteins activate T cells and promote hypertension

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4642-4656

  Kirabo, Annet ^a   Fontana, Vanessa ^b   De Faria, Ana P C ^b   Loperena, Roxana ^a   Galindo, Cristi L ^a   Wu, Jing ^a,c   Bikineyeva, Alfya T ^a   Dikalov, Sergey ^a   Xiao, Liang ^a   Chen, Wei ^a   Saleh, Mohamed A ^a,d   Trott, Daniel W ^a   Itani, Hana A ^a   Vinh, Antony ^e   Amarnath, Venkataraman ^a   Amarnath, Kalyani ^a   Guzik, Tomasz J ^f   Bernstein, Kenneth E ^g   Shen, Xiao Z ^g   Shyr, Yu ^a   Chen, Sheau Chiann ^a   Mernaugh, Raymond L ^c   Lafer, Cheryl L ^a   Elijovich, Fernando ^a   Davies, Sean S ^a,c   Moreno, Heitor ^b   Madhur, Meena S ^a   Roberts, Jackson ^a,c   Harrison, David G ^a,c   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MANSOURA UNIVERSITY   (Egypt)

^e MONASH UNIVERSITY   (Australia)

^f JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^g CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBENZYLAMINE; ANGIOTENSIN II; B7 ANTIGEN; BENZYLAMINE DERIVATIVE; CD86 ANTIGEN; GAMMA INTERFERON; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; UNCLASSIFIED DRUG; ALDEHYDE; OXYGEN; SUPEROXIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; KIDNEY INJURY; LIPID PEROXIDATION; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; OXIDATIVE STRESS; RESISTANT HYPERTENSION; T LYMPHOCYTE ACTIVATION; AGED; ANIMAL; ANTIGEN PRESENTING CELL; CELL PROLIFERATION; CHEMISTRY; COHORT ANALYSIS; CYTOLOGY; GENE EXPRESSION REGULATION; HYPERTENSION; IMMUNOLOGY; INFLAMMATION; KIDNEY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE;

AGED; ALDEHYDES; ANGIOTENSIN II; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; ANTIGENS, CD86; CELL PROLIFERATION; COHORT STUDIES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; KIDNEY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; SUPEROXIDES; T-LYMPHOCYTES;

EID: 84907494957     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74084     Document Type: Article

References (40)

1. Coffman TM. Under pressure: the search for the essential mechanisms of hypertension. Nat Med. 2011;17(11):1402-1409.
2. Luft FC, et al. Hypertension-induced end-organ damage: A new transgenic approach to an old problem. Hypertension. 1999;33(1 pt 2):212-218.
3. Muller DN, et al. Effect of bosentan on NF-?B, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension. 2000;36(2):282-290.
4. Nataraj C, et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1999;104(12):1693-1701.
5. Guzik TJ, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449-2460.
6. Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS, Ruiz P. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R1089-R1097.
7. Madhur MS, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55(2):500-507.
8. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17-58.
9. Vinh A, et al. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122(24):2529-2537.
10. Landmesser U, et al. Role of p47 (phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40(4):511-515.
11. Matsuno K, et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation. 2005;112(17):2677-2685.
12. Weber DS, et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005;288(1):37-42.
13. Davies SS, Amarnath V, Roberts LJ, 2nd. Isoketals: highly reactive γ-ketoaldehydes formed from the H2-isoprostane pathway. Chem Phys Lipids. 2004;128(1-2):85-99.
14. Roychowdhury S, McMullen MR, Pritchard MT, Li W, Salomon RG, Nagy LE. Formation of γ-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice. Free Radic Biol Med. 2009;47(11):1526-1538.
15. Salomon RG, et al. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta. 2000;1485(2-3):225-235.
16. Davies SS, et al. Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. J Alzheimers Dis. 2011;27(1):49-59.
17. Talati M, et al. Oxidant stress modulates murine allergic airway responses. Free Radic Biol Med. 2006;40(7):1210-1219.
18. Davies SS, et al. Pyridoxamine analogues scavenge lipid-derived γ-ketoaldehydes and protect against H2O2-mediated cytotoxicity. Biochemistry. 2006;45(51):15756-15767.
19. Davies SS, et al. Localization of isoketal adducts in vivo using a single-chain antibody. Free Radic Biol Med. 2004;36(9):1163-1174.
20. Zagol-Ikapitte I, et al. Characterization of scavengers of γ-ketoaldehydes that do not inhibit prostaglandin biosynthesis. Chem Res Toxicol. 2010;23(1):240-250.
21. Ishimitsu T, et al. Urinary excretions of albumin and type IV collagen in normotensive and hypertensive subjects. Hypertens Res. 2000;23(5):459-466.
22. Davies SS, Amarnath V, Brame CJ, Boutaud O, Roberts LJ 2nd. Measurement of chronic oxidative and inflammatory stress by quantification of isoketal/levuglandin γ-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry. Nat Protoc. 2007;2(9):2079-2091.
23. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300(2):535-543.
24. Lam GY, Huang J, Brumell JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol. 2010;32(4):415-430.
25. Park B, et al. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell. 2006;127(2):369-382.
26. Matsue H, et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol. 2003;171(6):3010-3018.
27. Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev. 2008;7(7):544-549.
28. Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res. 2013;97(4):696-704.
29. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2008;294(1):R76-R83.
30. Marko L, et al. Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension. 2012;60(6):1430-1436.
31. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 2009;93(3):621-635.
32. Widder JD, Harrison DG. Can vitamin E prevent cardiovascular events and cancer? Nat Clin Pract Cardiovasc Med. 2005;2(10):510-511.
33. Roberts LJ 2nd, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43(10):1388-1393.
34. Landmesser U, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111(8):1201-1209.
35. Wu J, et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res. 2014;114(4):616-625.
36. Kirabo A, Oh SP, Kasahara H, Wagner KU, Sayeski PP. Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice. J Mol Cell Cardiol. 2011;50(6):1026-1034.
37. Kirabo A, et al. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res. 2011;91(1):171-179.
38. Eden E, Lipson D, Yogev S, Yakhini Z. Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol. 2007;3(3):e39.
39. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48.
40. Calhoun DA, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117(25):e510-e512.